Literature DB >> 750194

The behaviour of infants whose mothers smoke in pregnancy.

D W Saxton.   

Abstract

The Brazelton Neonatal Behavioural Assessment Scale was used to compare the behaviour patterns of infants of mothers who smoked during pregnancy and those whose mothers did not smoke. Smokers were mothers who had smoked more than 15 cigarettes/day throughout their pregnancy. Over a period of 9 mth, a total of 32 infants (15 of whose mothers smoked and 17 whose mothers did not smoke) between 4 and 6 days of age were examined and the results compared. The two groups were matched for maternal age, social class and parity. All infants were spontaneously delivered at term and of normal birthweight. Sex distribution was equal. Duration of labour and analgesia during labour were similar for smokers and non-smokers. Examinations were carried out in a warm, quiet semi-dark room, the examiner being unaware of which category the infant was in. There was evidence to suggest that the behavioural patterns of infants can be influenced by smoking in pregnancy and that in particular the auditory senses are affected.

Entities:  

Mesh:

Year:  1978        PMID: 750194     DOI: 10.1016/0378-3782(78)90063-4

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  18 in total

1.  A critical period for nicotine-induced disruption of synaptic development in rat auditory cortex.

Authors:  V B Aramakis; C Y Hsieh; F M Leslie; R Metherate
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Prenatal tobacco exposure: developmental outcomes in the neonatal period.

Authors:  Kimberly Andrews Espy; Hua Fang; Craig Johnson; Christian Stopp; Sandra A Wiebe
Journal:  Dev Psychol       Date:  2011-01

Review 3.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

4.  Intravenous gestational nicotine exposure results in increased motivation for sucrose reward in adult rat offspring.

Authors:  Ryan T Lacy; Lauren L Hord; Amanda J Morgan; Steven B Harrod
Journal:  Drug Alcohol Depend       Date:  2012-02-27       Impact factor: 4.492

5.  Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through α4/β2/α5 nicotinic acetylcholine receptors.

Authors:  Christopher J Heath; Sarah L King; Cecilia Gotti; Michael J Marks; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

6.  Prenatal and infancy home visiting by nurses: from randomized trials to community replication.

Authors:  David L Olds
Journal:  Prev Sci       Date:  2002-09

7.  Cotinine concentrations in amniotic fluid and urine of smoking, passive smoking and non-smoking pregnant women at term and in the urine of their neonates on 1st day of life.

Authors:  J S Jordanov
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

Review 8.  Maternal smoking during pregnancy and child outcomes: real or spurious effect?

Authors:  Valerie S Knopik
Journal:  Dev Neuropsychol       Date:  2009       Impact factor: 2.253

Review 9.  Nicotine-induced plasticity during development: modulation of the cholinergic system and long-term consequences for circuits involved in attention and sensory processing.

Authors:  Christopher J Heath; Marina R Picciotto
Journal:  Neuropharmacology       Date:  2008-07-22       Impact factor: 5.250

10.  Prenatal and postnatal tobacco exposure and behavioral problems in 10-year-old children: results from the GINI-plus prospective birth cohort study.

Authors:  Simon Rückinger; Peter Rzehak; Chih-Mei Chen; Stefanie Sausenthaler; Sibylle Koletzko; Carl-Peter Bauer; Ute Hoffmann; Ursula Kramer; Dietrich Berdel; Andrea von Berg; Otmar Bayer; H-Erich Wichmann; Rüdiger von Kries; Joachim Heinrich
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.